Japanese Big Pharma, Big Dividends

Ono Pharmaceutical

Market Cap: JP¥725.1b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Takeda Pharmaceutical

Market Cap: JP¥6.5t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Santen Pharmaceutical

Market Cap: JP¥536.3b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Shionogi

Market Cap: JP¥2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Eisai

Market Cap: JP¥1.1t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Hisamitsu Pharmaceutical

Market Cap: JP¥303.1b

Manufactures and sells pharmaceuticals in Japan.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Astellas Pharma

Market Cap: JP¥2.5t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Otsuka Holdings

Market Cap: JP¥3.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Chugai Pharmaceutical

Market Cap: JP¥12.4t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥7.0t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.